Currently out of the existing stock ratings of Maury Raycroft, 86 are a BUY (81.13%), 20 are a HOLD (18.87%).

Maury Raycroft

Work Performance Price Targets & Ratings Chart

Analyst Maury Raycroft works at JEFFERIES with a stock forecast success ratio of 51.16% fulfilled within 145.06 days on average.

Maury Raycroft’s has documented 218 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 10-Oct-2023.

Wall Street Analyst Maury Raycroft

Analyst best performing recommendations are on ALNY (ALNYLAM PHARMACEUTICALS).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) at 9/18/2017. The price target of $102 was fulfilled within 2 days with a profit of $26 (34.21%) receiving and performance score of 171.05.

Average potential price target upside

AFMD Affimed NV ARWR Arrowhead Pharmaceuticals ATRA Atara Biotherapeutics AYLA Ayala Pharmaceuticals  BCRX BioCryst Pharmaceuticals CRBP Corbus Pharmaceuticals CRSP Crispr Therapeutics AG KALV Kalvista Pharmaceuticals MRTX Mirati Ther RETA Reata Pharmaceuticals SRRA Sierra Oncology ALLK Allakos ABEO Abeona Therapeutics ALNY Alnylam Pharmaceuticals EIGR Eiger Biopharmaceuticals NTLA Intellia Therapeutics BYSI BeyondSpring VALN Valneva SE ADR XENE Xenon Pharmaceuticals FMTX Forma Therapeutics Holdings KPTI Karyopharm Therapeutics RARE Ultragenyx SGMO Sangamo Therapeutics IMGO Imago Biosciences VERA Vera Therapeutics CNST Constellation Pharmaceuticals RTRX Travere Therapeutics SBPH Spring Bank Pharmaceuticals THRX Theseus Pharmaceuticals TYRA Tyra Biosciences RZLT Rezolute SPPI Spectrum Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

11

9 months 5 days ago

0/1 (0%)

$4.27 (63.45%)

Hold

1

$0.47 (88.68%)

2

11 months 5 days ago

2/3 (66.67%)

$0.34 (51.52%)

42

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Maury Raycroft is most bullish on?

Potential upside of $79 has been obtained for ALNY (ALNYLAM PHARMACEUTICALS)

Which stock is Maury Raycroft is most reserved on?

Potential downside of -$0.7 has been obtained for MRTX (MIRATI THER)

What Year was the first public recommendation made by Maury Raycroft?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?